...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: DSMB 5 postitive recomendation

Brief text:

 
BRIEF-Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for Apabetalone
2017-11-01 08:41:08 AM ET (Reuters)
   
   

Nov 1 (Reuters) - Resverlogix Corp

* Resverlogix announces fifth positive recommendation from Data Safety Monitoring Board for phase 3 study of Apabetalone

* Resverlogix - ‍independent DSMB recommended phase 3 study of Apabetalone should continue as planned without modifications ​

* Resverlogix Corp - ‍full enrollment for phase 3 study of apabetalone now anticipated in first half of 2018​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

2
Nov 01, 2017 09:36AM
4
Nov 01, 2017 10:56AM
Share
New Message
Please login to post a reply